MATTHEW CLARK: Open Payments
NPI 1942060355 · ELIZABETHTOWN, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,439 in 73 payments from 19 companies in 2025. Trend: 2023 $0 · 2024 $1,856 · 2025 $2,439
Food & beverage: $1,889Travel & lodging: $550
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 8 | $794 |
| Novo Nordisk Inc | 14 | $382 |
| SANOFI-AVENTIS U.S. LLC | 6 | $269 |
| BETA BIONICS, INC. | 5 | $200 |
| Insulet Corporation | 10 | $161 |
| Corcept Therapeutics | 5 | $148 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $108 |
| CeQur Corporation | 1 | $61 |
| Mannkind Corporation | 2 | $60 |
| Tandem Diabetes Care, Inc. | 4 | $46 |
Products named: MINIMED 780G, TZIELD, iLet Bionic Pancreas, Ozempic, Omnipod, Korlym, Rybelsus, Kerendia.
Industry payments across KY — which companies pay providers there.
